The Impact of Antidiabetic Therapy on Liver Injury, Steatosis, and Fibrosis in Patients with Type 2 Diabetes and Metabolic Dysfunction-Associated Steatotic Liver Disease

<i>Background and Objectives</i>: Metabolic dysfunction-associated steatotic liver disease (MASLD) is closely linked with type 2 diabetes mellitus (T2D) and obesity. Despite its growing prevalence, effective pharmacological interventions remain limited, with antidiabetic agents such as glucagon-like...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Oana Albai, Adina Braha, Romulus Timar, Sandra Lazăr, Simona Popescu, Bogdan Timar
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	MDPI AG 2025-10-01
Edice:	Medicina
Témata:	MASLD hepatic steatosis fibrosis metabolic syndrome insulin resistance type 2 diabetes
On-line přístup:	https://www.mdpi.com/1648-9144/61/10/1850
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!